Covered recipient · General Payments record
DEEPANWITA PRUSTY
General Payments · PY2018–2024
$2,018.09
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $517.59 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $283.33 | 16 |
| ABBVIE INC. | $58.25 | 2 |
| MannKind Corporation | $57.11 | 3 |
| DEXCOM, INC. | $32.82 | 1 |
| Xeris Pharmaceuticals, Inc. | $22.95 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.76 | 1 |
| Lilly USA, LLC | $20.98 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.86 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113853253 | CMS |
| ABBVIE INC. | $32.39 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113853261 | CMS |
| Alexion Pharmaceuticals, Inc. | $20.39 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110543363 | CMS |
| Amgen Inc. | $31.43 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680292 | CMS |
| Amgen Inc. | $3.48 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680294 | CMS |
| Amgen Inc. | $25.25 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680296 | CMS |
| Amgen Inc. | $8.27 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680298 | CMS |
| Amgen Inc. | $24.97 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680300 | CMS |
| Amgen Inc. | $11.95 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680302 | CMS |
| Amgen Inc. | $19.44 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680320 | CMS |
| Amgen Inc. | $22.89 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680318 | CMS |
| Amgen Inc. | $23.27 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680304 | CMS |
| Amgen Inc. | $28.58 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680306 | CMS |
| Amgen Inc. | $9.61 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680308 | CMS |
| Amgen Inc. | $23.63 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680322 | CMS |
| Amgen Inc. | $25.89 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680310 | CMS |
| Amgen Inc. | $7.29 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680312 | CMS |
| Amgen Inc. | $10.98 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680314 | CMS |
| Amgen Inc. | $6.40 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111680316 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.76 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118193140 | CMS |
| Dexcom, Inc. | $32.82 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153295961 | CMS |
| Lilly USA, LLC | $20.98 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136140369 | CMS |
| Mannkind Corporation | $18.38 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145847781 | CMS |
| Mannkind Corporation | $18.52 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145847783 | CMS |
| Mannkind Corporation | $20.21 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145847785 | CMS |
| Xeris Pharmaceuticals, Inc. | $22.95 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144592432 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.